Association Briefs

Public Interest In Science Surges The public’s interest in science has boomed in the last decade and science museums are proliferating in response. According to preliminary findings of an international study conducted by the Association of Science-Technology Centers, attendance at U.S. science centers grew 38% from 1979 to 1986. In addition, 16% of the 131 institutions responding said they had been founded within the past seven years. Even more indicative of the growth trend: four out o

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The public’s interest in science has boomed in the last decade and science museums are proliferating in response. According to preliminary findings of an international study conducted by the Association of Science-Technology Centers, attendance at U.S. science centers grew 38% from 1979 to 1986. In addition, 16% of the 131 institutions responding said they had been founded within the past seven years. Even more indicative of the growth trend: four out of five respondents plan to expand or move to a new facility during the next five years.

Does the public know enough about biotechnology? Warren Hyer thinks not. Last month, Hyer founded the American Biotechnology Association to increase the public’s interest and involvement in the new technology. While Hyer has a biotech background—he has been a consultant to the Washington-based Association of Biotechnology Companies and he organized the first International Symposium on Large-scale Bioprocessing Safety in Washington last fall—he ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies